2025. Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s539. DOI:https://doi.org/10.25251/skin.10.supp.539.